Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: a retrospective analysis of the Rete Ematologica Lombarda.
Bernardi M, Zappasodi P, Fracchiolla N, Marbello L, Todisco E, Pagani C, Carrabba M, Rossi M, Guidotti F, Mancini V, Santoro A, Borlenghi E, Ciceri F, Morra E, Rossi G. Bernardi M, et al. Among authors: morra e. Am J Hematol. 2015 Jun;90(6):E123-5. doi: 10.1002/ajh.23990. Epub 2015 May 3. Am J Hematol. 2015. PMID: 25715978 Free article. No abstract available.
Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.
Nosari A, Marbello L, De Carlis LG, De Gasperi A, Muti G, Mancini V, Morra E. Nosari A, et al. Among authors: morra e. Int J Hematol. 2004 Feb;79(2):130-2. doi: 10.1532/ijh97.e0213. Int J Hematol. 2004. PMID: 15005339
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Alessandrino EP, et al. Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30. Am J Hematol. 2013. PMID: 23606215 Free PMC article. Clinical Trial.
High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A, Montillo M, Strocchi E, Cafro AM, Tresoldi E, Intropido L, Nichelatti M, Marbello L, Baratè C, Camaggi CM, Morra E. Tedeschi A, et al. Among authors: morra e. Cancer Chemother Pharmacol. 2007 May;59(6):771-9. doi: 10.1007/s00280-006-0332-4. Epub 2007 Jan 26. Cancer Chemother Pharmacol. 2007. PMID: 17256136 Clinical Trial.
Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: a REL (Rete Ematologica Lombarda) experience.
Arcaini L, Laszlo D, Rizzi S, Balzarotti M, Antoniazzi F, Zilioli VR, Guggiari E, Farina L, Todisco E, Bonfichi M, Alamos SM, Rossi G, Martinelli G, Morra E. Arcaini L, et al. Among authors: morra e. Leuk Res. 2011 Jun;35(6):712-4. doi: 10.1016/j.leukres.2010.12.036. Epub 2011 Jan 26. Leuk Res. 2011. PMID: 21276613 Clinical Trial.
Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the "International Working Group" criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience.
Molteni A, Riva M, Greco R, Nichelatti M, Ravano E, Marbello L, Nosari A, Morra E. Molteni A, et al. Among authors: morra e. Int J Hematol. 2013 Apr;97(4):472-9. doi: 10.1007/s12185-013-1305-0. Epub 2013 Mar 19. Int J Hematol. 2013. PMID: 23508542
356 results